127 related articles for article (PubMed ID: 22954307)
21. Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity.
Matsuda K; Hattori S; Kariya R; Komizu Y; Kudo E; Goto H; Taura M; Ueoka R; Kimura S; Okada S
Biochem Biophys Res Commun; 2015 Feb; 457(3):288-94. PubMed ID: 25576356
[TBL] [Abstract][Full Text] [Related]
22. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.
Rosemary Bastian A; Nangarlia A; Bailey LD; Holmes A; Kalyana Sundaram RV; Ang C; Moreira DR; Freedman K; Duffy C; Contarino M; Abrams C; Root M; Chaiken I
J Biol Chem; 2015 Jan; 290(1):529-43. PubMed ID: 25371202
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 entry inhibitors: classes, applications and factors affecting potency.
Sterjovski J; Churchill MJ; Wesselingh SL; Gorry PR
Curr HIV Res; 2006 Oct; 4(4):387-400. PubMed ID: 17073614
[TBL] [Abstract][Full Text] [Related]
25. Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.
Ohashi N; Harada S; Mizuguchi T; Irahara Y; Yamada Y; Kotani M; Nomura W; Matsushita S; Yoshimura K; Tamamura H
ChemMedChem; 2016 Apr; 11(8):940-6. PubMed ID: 26891461
[TBL] [Abstract][Full Text] [Related]
26. A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Xiong S; Borrego P; Ding X; Zhu Y; Martins A; Chong H; Taveira N; He Y
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795437
[TBL] [Abstract][Full Text] [Related]
27. Targeting HIV attachment and entry for therapy.
Strizki J
Adv Pharmacol; 2008; 56():93-120. PubMed ID: 18086410
[No Abstract] [Full Text] [Related]
28. Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion.
Guerrero-Beltran C; Rodriguez-Izquierdo I; Serramia MJ; Araya-Durán I; Márquez-Miranda V; Gomez R; de la Mata FJ; Leal M; González-Nilo F; Muñoz-Fernández MA
Bioconjug Chem; 2018 May; 29(5):1584-1594. PubMed ID: 29570280
[TBL] [Abstract][Full Text] [Related]
29. Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion.
Finnegan CM; Rawat SS; Cho EH; Guiffre DL; Lockett S; Merrill AH; Blumenthal R
J Virol; 2007 May; 81(10):5294-304. PubMed ID: 17344303
[TBL] [Abstract][Full Text] [Related]
30. Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements.
Iusupov IR; Curreli F; Spiridonov EA; Markov PO; Ahmed S; Belov DS; Manasova EV; Altieri A; Kurkin AV; Debnath AK
Eur J Med Chem; 2021 Nov; 224():113681. PubMed ID: 34246921
[TBL] [Abstract][Full Text] [Related]
31. [Originality of entry inhibitors].
Izopet J
Med Mal Infect; 2009 Oct; 39(10 Suppl 1):H1-4. PubMed ID: 19837343
[No Abstract] [Full Text] [Related]
32. Characterizing the anti-HIV activity of papuamide A.
Andjelic CD; Planelles V; Barrows LR
Mar Drugs; 2008; 6(4):528-49. PubMed ID: 19172193
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetics, interactions and mechanism of action of maraviroc].
Soriano V; Poveda E
Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 11():12-6. PubMed ID: 19133216
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 gp41: mediator of fusion and target for inhibition.
Weiss CD
AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
[TBL] [Abstract][Full Text] [Related]
35. Co-delivery of HIV-1 entry inhibitor and nonnucleoside reverse transcriptase inhibitor shuttled by nanoparticles: cocktail therapeutic strategy for antiviral therapy.
Li W; Yu F; Wang Q; Qi Q; Su S; Xie L; Lu L; Jiang S
AIDS; 2016 Mar; 30(6):827-38. PubMed ID: 26595538
[TBL] [Abstract][Full Text] [Related]
36. FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes.
Ono M; Wada Y; Wu Y; Nemori R; Jinbo Y; Wang H; Lo KM; Yamaguchi N; Brunkhorst B; Otomo H; Wesolowski J; Way JC; Itoh I; Gillies S; Chen LB
Nat Biotechnol; 1997 Apr; 15(4):343-8. PubMed ID: 9094135
[TBL] [Abstract][Full Text] [Related]
37. Reduced Susceptibility to VIRIP-Based HIV-1 Entry Inhibitors Has a High Genetic Barrier and Severe Fitness Costs.
Müller JA; Glöckle A; Gawanbacht A; Geyer M; Münch J; Kirchhoff F
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925662
[TBL] [Abstract][Full Text] [Related]
38. [Virtual screening of small molecular HIV-1 entry inhibitor NC-2 targeting gp120 and its action mechanism].
Duan H; Wang Y; Song D; Chen Z; Qiu J; Lu L; Jiang S; Liu S; Tan S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):826-31. PubMed ID: 23803191
[TBL] [Abstract][Full Text] [Related]
39. Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors.
Das D; Maeda K; Hayashi Y; Gavande N; Desai DV; Chang SB; Ghosh AK; Mitsuya H
Antimicrob Agents Chemother; 2015 Apr; 59(4):1895-904. PubMed ID: 25583709
[TBL] [Abstract][Full Text] [Related]
40. 3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry.
Li L; Qiu J; Lu L; An S; Qiao P; Jiang S; Liu S
J Antimicrob Chemother; 2013 Mar; 68(3):573-6. PubMed ID: 23221626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
